Mir-32 microRNA precursor family

mir-32
Identifiers
Symbol	mir-32
Rfam	RF00666
miRBase family	MIPF0000069
Other data
RNA type	microRNA
Domain(s)	Eukaryota;
PDB structures	PDBe

In molecular biology mir-32 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.

References

Mishra R, Chhatbar C, Singh SK (June 2012). "HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia". Journal of Neuroinflammation. 9 (1): 131. doi:10.1186/1742-2094-9-131. PMC 3418571. PMID 22709905.
Shin D, Howng SY, Ptáček LJ, Fu YH (June 2012). "miR-32 and its target SLC45A3 regulate the lipid metabolism of oligodendrocytes and myelin". Neuroscience. 213: 29–37. doi:10.1016/j.neuroscience.2012.03.054. PMC 3370422. PMID 22521588.
Zhang S, Chen H, Zhao X, Cao J, Tong J, Lu J, Wu W, Shen H, Wei Q, Lu D (January 2013). "REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility". Oncogene. 32 (2): 242–50. doi:10.1038/onc.2012.32. PMID 22349819.
Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL, Visakorpi T (October 2012). "Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer". Oncogene. 31 (41): 4460–71. doi:10.1038/onc.2011.624. PMID 22266859.
Yu XF, Zou J, Bao ZJ, Dong J (November 2011). "miR-93 suppresses proliferation and colony formation of human colon cancer stem cells". World Journal of Gastroenterology. 17 (42): 4711–7. doi:10.3748/wjg.v17.i42.4711. PMC 3233678. PMID 22180714.
Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, Camara-Lopes LH, Srougi M (August 2013). "MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis". Urologic Oncology. 31 (6): 796–801. doi:10.1016/j.urolonc.2011.07.002. PMID 21880514.
Li X, Luo F, Li Q, Xu M, Feng D, Zhang G, Wu W (December 2011). "Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance". Oncology Reports. 26 (6): 1431–9. doi:10.3892/or.2011.1437. PMID 21874264.
Gocek E, Wang X, Liu X, Liu CG, Studzinski GP (October 2011). "MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis". Cancer Research. 71 (19): 6230–9. doi:10.1158/0008-5472.CAN-11-1717. PMC 5572464. PMID 21816906.
Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, Wolen AR, Mba MU, Massey HD, King AL, Gehr T, Cotterell A, Posner M, Mas V (October 2011). "MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA". American Journal of Transplantation. 11 (10): 2110–22. doi:10.1111/j.1600-6143.2011.03666.x. PMC 3184368. PMID 21794090.
Mahn R, Heukamp LC, Rogenhofer S, von Ruecker A, Müller SC, Ellinger J (May 2011). "Circulating microRNAs (miRNA) in serum of patients with prostate cancer". Urology. 77 (5): 1265.e9–16. doi:10.1016/j.urology.2011.01.020. PMID 21539977.
Dacic S, Kelly L, Shuai Y, Nikiforova MN (December 2010). "miRNA expression profiling of lung adenocarcinomas: correlation with mutational status". Modern Pathology. 23 (12): 1577–82. doi:10.1038/modpathol.2010.152. PMID 20818338.
Haflidadóttir BS, Bergsteinsdóttir K, Praetorius C, Steingrímsson E (July 2010). Jin DY (ed.). "miR-148 regulates Mitf in melanoma cells". PLOS ONE. 5 (7): e11574. doi:10.1371/journal.pone.0011574. PMC 2904378. PMID 20644734.
Leite KR, Canavez JM, Reis ST, Tomiyama AH, Piantino CB, Sañudo A, Camara-Lopes LH, Srougi M (2011). "miRNA analysis of prostate cancer by quantitative real time PCR: comparison between formalin-fixed paraffin embedded and fresh-frozen tissue". Urologic Oncology. 29 (5): 533–7. doi:10.1016/j.urolonc.2009.05.008. PMID 19734068.
Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT (July 2009). "MicroRNA profiling of human kidney cancer subtypes". International Journal of Oncology. 35 (1): 109–14. doi:10.3892/ijo_00000318. PMID 19513557.
Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S (July 2009). "CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis". Genes, Chromosomes & Cancer. 48 (7): 615–23. doi:10.1002/gcc.20669. PMID 19396864. S2CID 22482567.
Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, Burny A, Sculier JP (February 2009). "Evolution of microRNA expression during human bronchial squamous carcinogenesis". The European Respiratory Journal. 33 (2): 352–9. doi:10.1183/09031936.00084108. PMID 19010987.
Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro M, Garzon R, Palumbo A, Aqeilan RI, Croce CM (September 2008). "MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis". Proceedings of the National Academy of Sciences of the United States of America. 105 (35): 12885–90. doi:10.1073/pnas.0806202105. hdl:2318/78538. PMC 2529070. PMID 18728182.
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, Yfantis HG, Stephens RM, Croce CM (August 2008). "Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer". Cancer Research. 68 (15): 6162–70. doi:10.1158/0008-5472.CAN-08-0144. PMC 2597340. PMID 18676839.
Palmieri A, Pezzetti F, Brunelli G, Martinelli M, Scapoli L, Arlotti M, Masiero E, Carinci F (2008). "Medpor regulates osteoblast's microRNAs". Bio-Medical Materials and Engineering. 18 (2): 91–7. doi:10.3233/BME-2008-0512. PMID 18408260.
Choong ML, Yang HH, McNiece I (April 2007). "MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis". Experimental Hematology. 35 (4): 551–64. doi:10.1016/j.exphem.2006.12.002. PMID 17379065.